| Literature DB >> 34530446 |
Wenliang Zhang1,2,3, Yang Liu2,4,5, Zhuochao Min6, Guodong Liang7, Jing Mo3, Zhen Ju2,8,9, Binghui Zeng10,3, Wen Guan3,11, Yan Zhang2, Jianliang Chen1, Qianshen Zhang1, Hanguang Li1, Chunxia Zeng2,8,9, Yanjie Wei2,8,9, Godfrey Chi-Fung Chan1,12.
Abstract
Many circRNA transcriptome data were deposited in public resources, but these data show great heterogeneity. Researchers without bioinformatics skills have difficulty in investigating these invaluable data or their own data. Here, we specifically designed circMine (http://hpcc.siat.ac.cn/circmine and http://www.biomedical-web.com/circmine/) that provides 1 821 448 entries formed by 136 871 circRNAs, 87 diseases and 120 circRNA transcriptome datasets of 1107 samples across 31 human body sites. circMine further provides 13 online analytical functions to comprehensively investigate these datasets to evaluate the clinical and biological significance of circRNA. To improve the data applicability, each dataset was standardized and annotated with relevant clinical information. All of the 13 analytic functions allow users to group samples based on their clinical data and assign different parameters for different analyses, and enable them to perform these analyses using their own circRNA transcriptomes. Moreover, three additional tools were developed in circMine to systematically discover the circRNA-miRNA interaction and circRNA translatability. For example, we systematically discovered five potential translatable circRNAs associated with prostate cancer progression using circMine. In summary, circMine provides user-friendly web interfaces to browse, search, analyze and download data freely, and submit new data for further integration, and it can be an important resource to discover significant circRNA in different diseases.Entities:
Mesh:
Substances:
Year: 2022 PMID: 34530446 PMCID: PMC8728235 DOI: 10.1093/nar/gkab809
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Figure 1.The scheme for data collection and manual curation (A) and the web application framework of circMine (B); GO, Gene Ontology; IRES, internal ribosome entry site element; KEGG, Kyoto Encyclopedia of Genes and Genomes; PCA, Principal Component Analysis.
The description of the 13 analytical functions in the differential expression and co-expression modules
| Web analysis | Description |
|---|---|
|
| |
| General analysis | To conduct a heatmap plot, principal component analysis and box plot on the data |
| Differential expression | To identify all of significant differential circRNA between two conditions |
| Boxplot | To present the expression difference of a circRNA on different conditions as a box plot |
| Volcano plot | To depict the expression difference of one or more circRNAs between two conditions as a volcano plot |
| Heatmap plot | To depict the circRNA expression pattern on different conditions as a heatmap |
| GO enrichment | GO enrichment on the host genes of the differential circRNAs between two conditions |
| KEGG enrichment | KEGG enrichment on the host genes of the differential circRNAs between two conditions |
|
| |
| Co-expression | To present correlation analysis of a circRNA with all of circRNAs on specific conditions |
| Linear graph | To present the correlationship of two circRNAs on specific conditions |
| Boxplot | To conduct paired correlation analysis of two circRNAs on specific conditions |
| Corrplot | To depict the correlationships among multiple circRNAs on specific conditions |
| GO enrichment | GO enrichment on the host genes of the co-expression circRNAs on specific conditions |
| KEGG enrichment | KEGG enrichment on the host genes of the co-expression circRNAs on specific conditions |
Figure 2.The circRNA differential expression analysis results from five low (Gleason < 6) and five high (Gleason > 8) grade prostate cancer tissues. (A) The heatmap plot shows significantly different circRNA expression profile between the two groups. (B) The pie chart indicates the numbers and percentages of deregulated, up-regulated and down-regulated circRNAs. (C) The bar and dot plot to show the GO and KEGG enrichment results from the 2052 deregulated circRNAs (|logFC| ≥ 1.0 and P-value ≤ 0.05), respectively.
Figure 3.Deregulated ribo-circRNA significantly distinguished different grades of prostate cancer regardless of the subcellular localization of their putative peptides and proteins. (A) The distribution of subcellular localization of the 263 putative peptides and proteins translated by the 190 deregulated ribo-circRNAs. (B) The heatmaps show that the 190 ribo-circRNAs significantly distinguish different grade prostate cancer regardless of the subcellular localization of their putative peptides and proteins.
Figure 4.Comprehensive investigation to discover potential translatable circRNAs and identify their biological and clinical significance in prostate cancer progression. (A) Of the 2052 deregulated circRNAs, 190 circRNAs are ribo-circRNA, 79 circRNAs have human IRES(s) (E-value ≤ 1E-5), and five circRNAs are ribo-circRNA and have experimentally validated human IRES(s), including hsa_circ_0003700, hsa_circ_0003458, hsa_circ_0001112, hsa_circ_0008351 and hsa_circ_0003643. (B) The volcano plot shows that the five circRNAs are significantly different between low- and high- grade prostate cancers. (C) The corrplot diagram shows that the expression patterns of the five circRNAs are significantly correlated with each other. *: P-value ≤ 0.05, **: P-value ≤ 0.01 and ***: P-value ≤ 0.001. (D–H) The GO and KEGG enrichment of the five circRNAs based the annotations of the host genes of their co-expression circRNAs (|Correlation| ≥ 0.8 and P-value ≤ 0.05).